Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury

Overview

Journal Crit Care Clin

Specialty Critical Care

Date 2015 Sep 28

PMID 26410136

Citations 25

Authors

Trung C Nguyen

Miguel A Cruz

Joseph A Carcillo

Affiliations

Soon will be listed here.

Abstract

Thrombocytopenia-associated multiple organ failure (TAMOF) is a clinical phenotype that encompasses a spectrum of syndromes associated with disseminated microvascular thromboses, such as the thrombotic microangiopathies thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) and disseminated intravascular coagulation (DIC). Autopsies findings in TTP, HUS, or DIC reveal specific findings that can differentiate these 3 entities. Von Willebrand factor and ADAMTS-13 play a central role in TTP. Shiga toxins and the complement pathway are vital in the development of HUS. Tissue factor is the major protease that drives the pathology of DIC. Acute kidney injury (AKI) is a common feature in patients with TAMOF.

Citing Articles

Current perspectives in the management of sepsis and septic shock.

Chiscano-Camon L, Ruiz-Sanmartin A, Bajana I, Bastidas J, Lopez-Martinez R, Franco-Jarava C Front Med (Lausanne). 2024; 11:1431791.

PMID: 39211340 PMC: 11358069. DOI: 10.3389/fmed.2024.1431791.

Scrub Typhus with Multi-Organ Dysfunction Syndrome and Immune Thrombocytopenia: A Case Report.

Lallawmkima I, Vanlalruati R, Chongthu J, Renthlei L Infect Dis Clin Microbiol. 2024; 4(2):133-136.

PMID: 38633345 PMC: 10986586. DOI: 10.36519/idcm.2022.95.

Navigating the Labyrinth: Intensive Care Challenges for Patients with Acute-on-Chronic Liver Failure.

Saner F, Raptis D, Alghamdi S, Malago M, Broering D, Bezinover D J Clin Med. 2024; 13(2).

PMID: 38256640 PMC: 10816826. DOI: 10.3390/jcm13020506.

Acute Pancreatitis Induced Thrombotic Microangiopathy with Acute Renal Failure: A Rare Complication!.

Bhardwaj A, Deswal S, Mohan N JPGN Rep. 2023; 2(1):e038.

PMID: 37206945 PMC: 10191473. DOI: 10.1097/PG9.0000000000000038.

Development and validation of a prediction model for in-hospital mortality of patients with severe thrombocytopenia.

Lu Y, Zhang Q, Jiang J Sci Rep. 2022; 12(1):6316.

PMID: 35428822 PMC: 9012749. DOI: 10.1038/s41598-022-10438-y.

References

Sadler J . Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998; 67:395-424. DOI: 10.1146/annurev.biochem.67.1.395. View

Johannes L, Romer W . Shiga toxins--from cell biology to biomedical applications. Nat Rev Microbiol. 2009; 8(2):105-16. DOI: 10.1038/nrmicro2279. View

Lapeyraque A, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M . Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med. 2011; 364(26):2561-3. DOI: 10.1056/NEJMc1100859. View

Noris M, Mescia F, Remuzzi G . STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol. 2012; 8(11):622-33. DOI: 10.1038/nrneph.2012.195. View

Stephan F, Hollande J, Richard O, Cheffi A, Flahault A . Thrombocytopenia in a surgical ICU. Chest. 1999; 115(5):1363-70. DOI: 10.1378/chest.115.5.1363. View

Chow T, Turner N, Chintagumpala M, McPherson P, Nolasco L, Rice L . Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol. 1998; 57(4):293-302. DOI: 10.1002/(sici)1096-8652(199804)57:4<293::aid-ajh5>3.0.co;2-p. View

Aoki N, Matsuda T, Saito H, Takatsuki K, Okajima K, Takahashi H . A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation. Int J Hematol. 2002; 75(5):540-7. DOI: 10.1007/BF02982120. View

Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D . Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med. 2009; 37(4):1185-96. DOI: 10.1097/CCM.0b013e31819c06bc. View

Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K . Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res. 1985; 38(5):469-79. DOI: 10.1016/0049-3848(85)90180-x. View

10.

Arya M, Anvari B, Romo G, Cruz M, Dong J, McIntire L . Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood. 2002; 99(11):3971-7. DOI: 10.1182/blood-2001-11-0060. View

11.

Levi M, van der Poll T . Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med. 2012; 8(1):23-32. DOI: 10.1007/s11739-012-0859-9. View

12.

Nurnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba H . Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 360(5):542-4. DOI: 10.1056/NEJMc0808527. View

13.

Tarr P, Gordon C, Chandler W . Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005; 365(9464):1073-86. DOI: 10.1016/S0140-6736(05)71144-2. View

14.

Green J, Doughty L, Kaplan S, Sasser H, Carcillo J . The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure. Thromb Haemost. 2002; 87(2):218-23. View

15.

van der Poll T, Levi M, Hack C, ten Cate H, van Deventer S, Eerenberg A . Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 1994; 179(4):1253-9. PMC: 2191443. DOI: 10.1084/jem.179.4.1253. View

16.

Levi M, de Jonge E, van der Poll T . Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med. 2001; 29(7 Suppl):S90-4. DOI: 10.1097/00003246-200107001-00028. View

17.

Chen J, Fu X, Wang Y, Ling M, McMullen B, Kulman J . Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. Blood. 2009; 115(3):706-12. PMC: 2810979. DOI: 10.1182/blood-2009-03-213967. View

18.

Akca S, Haji-Michael P, De Mendonca A, Suter P, Levi M, Vincent J . Time course of platelet counts in critically ill patients. Crit Care Med. 2002; 30(4):753-6. DOI: 10.1097/00003246-200204000-00005. View

19.

CORRIGAN Jr J . Thrombocytopenia: a laboratory sign of septicemia in infants and children. J Pediatr. 1974; 85(2):219-21. DOI: 10.1016/s0022-3476(74)80396-3. View

20.

Noris M, Remuzzi G . Atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 361(17):1676-87. DOI: 10.1056/NEJMra0902814. View